Bears Circle Biotech, Prison Stocks, and Chewy
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Short sellers are busy this week. Data from August 11 shows sharp moves across biotech, consumer names, and a surprise in the private-prison sector.
CoreCivic saw the sharpest week-on-week jump among mid-caps. SI % of FF leapt from 2.4% to 10.2% — a near-fourfold rise in seven days. The move follows renewed debate around federal detention policy.
Replimune is another standout. SI climbed to 43.8% of free float, up from 35.7% last week — an 8-point spike. The cancer-therapy biotech carries a cost to borrow of just 0.8%, suggesting bears still have easy access.
Chewy remains the most striking large-cap on the screen. SI sits at 95.6% of free float — deep short territory. Availability is ample at 477%, so pressure has not yet triggered a squeeze.
Hertz continues to attract attention on social platforms. SI holds at 68.9% of float. Availability is zero. Cost to borrow is 27.9%. Those are squeeze conditions worth watching.
EverCommerce carries the highest ORTEX short score among mid-caps at 94.9. Cost to borrow jumped to 60%. Shares available to borrow equal just 2% of short interest — the tightest squeeze setup in the screen.
On the other side, ORTEX data shows UDR shorts retreating fast. SI fell 21% in a single day to 2.4% of float, down 44.9% over the past month.
Stocks in this article
How this article was generated
- Generated
- 12 Aug 2026, 16:04
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilization
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.